Messner M, Deugnier Y, Bernard-Griffiths I, Delamaire D, Estable P, Friguet J L, Le Gall M, Brissot P, Bourel M
Gastroenterol Clin Biol. 1985 Jan;9(1):42-6.
Ultrasonically guided fine needle aspiration biopsy is known to be of great value in the diagnosis of malignant liver disease, with an overall accuracy rate of 73-94 p. 100. However, investigators have essentially reported cases of liver metastases. In this report, we examined the diagnostic value of this method in the specific case of tumors associated with cirrhosis. Twenty-seven patients with cirrhosis (20 alcoholic, 4 post-hepatitis, 3 hemochromatosis) with ultrasonically suspected hepatic malignancy were studied. They all presented severe blood clotting disturbances and/or ascites. At the end of the study, all patients had proven malignancy (by post mortem biopsy in 14 cases and/or serum AFP greater than 500 microgram/l in 17 cases). There were 25 primary and 2 metastatic tumors. Twenty-nine fine needle aspiration biopsies were performed under ultrasonic guidance. material suitable for cytologic evaluation was obtained in 25 patients. In 14 cases, a diagnosis of malignant involvement of the liver was firmly established by cytological examination; it was suggested in 4 other cases. Tumor typing was possible in 12 primary and 2 metastatic tumors, in agreement with the proven diagnosis. The present study shows that fine needle aspiration biopsy under ultrasound guidance is a safe and accurate diagnostic procedure in malignant liver disease associated with cirrhosis.
超声引导下细针穿刺活检在恶性肝脏疾病的诊断中具有重要价值,总体准确率为73%至94%。然而,此前的研究基本上都报告的是肝转移瘤病例。在本报告中,我们研究了该方法在伴有肝硬化的肿瘤这一特定病例中的诊断价值。对27例伴有超声怀疑肝脏恶性肿瘤的肝硬化患者(20例酒精性肝硬化、4例肝炎后肝硬化、3例血色素沉着症)进行了研究。所有患者均存在严重凝血功能障碍和/或腹水。研究结束时,所有患者均被证实患有恶性肿瘤(14例经尸检活检证实,17例血清甲胎蛋白大于500微克/升)。其中有25例原发性肿瘤和2例转移性肿瘤。在超声引导下进行了29次细针穿刺活检。25例患者获取了适合细胞学评估的材料。14例通过细胞学检查明确诊断为肝脏恶性病变;另外4例提示可能为恶性病变。12例原发性肿瘤和2例转移性肿瘤能够进行肿瘤分型,与最终确诊结果相符。本研究表明,超声引导下细针穿刺活检对于伴有肝硬化的恶性肝脏疾病是一种安全、准确的诊断方法。